Bushenshugan Formula Attenuates the Development of Lung Cancer by Inhibiting Epithelial-Mesenchymal Transition
Zhirui Fan(First Affiliated Hospital of Zhengzhou University), Jie Zhao(First Affiliated Hospital of Zhengzhou University), Bingjun Ma(First Affiliated Hospital of Zhengzhou University), Jingli Lü(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Lifeng Li(Genesis Medical Center), Shuling Wang(Shenyang Pharmaceutical University), Yunkai Zhai(Zhengzhou University), Xiaoming Deng(Second Military Medical University), Mengmeng Dou(First Affiliated Hospital of Zhengzhou University), Wenhua Xue(First Affiliated Hospital of Zhengzhou University)
Cited by 12
Related Papers
The genesis and source of the H7N9 influenza viruses causing human infections in China
|Nature|2013|479
Serum miR-146a and miR-223 as potential new biomarkers for sepsis
|Biochemical and Biophysical Research Communications|2010|361
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
|Critical Care|2010|307
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296